Hormesis: An Overview of the Pubmed Literature


Hormesis is when some things that are bad for you in high doses are actually good for you in low to medium doses -- including radioactivity -- which upsets Greenie scares about leaks of radioactivity.

On balance, it's probable that the Chernobyl meltdown did more good than harm, even to life in the surrounding area. Life is certainly flourishing there better than ever these days. Pesky!


Dr. Ronald N. Kostoff

OVERVIEW

The purpose of this Op-ed is to provide a broad overview of the Pubmed literature in Hormesis (a biphasic dose-response phenomenon characterized by a low-dose stimulation and a high-dose inhibition). A unique query was developed to retrieve this literature, and many Hormetins (any stress condition that is able to induce Hormesis) were identified. Hormesis has been a controversial topic because of its potential for modifying exposure limit regulations. Critical articles addressing both sides of this issue are also presented in the next section.

INTRODUCTION AND BACKGROUND

“Hormesis is a biphasic dose-response phenomenon characterized by a low-dose stimulation and a high-dose inhibition”. “Specific aspects of this general nonlinearity phenomenon have been described using various terms mainly addressing the shape of the dose-response curve, as biphasic, bimodal, bitonic, U shaped, inverted U-shaped, J-shaped, nonmonotonic, functional metabolism and stimulatory inhibitory, among others…..

Furthermore, terms such as adaptive response, preconditioning, autoprotection, heteroprotection, paradoxical and others have also been used to describe the shape of the dose-response patterns”. “Hormesis is a special type of biphasic dose-response relationship that has well-defined, quantitative features, including the magnitude and the width of the stimulatory zone and the relationship of the stimulatory zone to the traditional toxicological threshold (no-observed-adverse-effect level)…..

The hormetic dose response also must be seen within a temporal context–that is, as a dose-time-response relationship. The reason for incorporating a temporal feature in hormesis is that it also may be described as a modest over-compensation response following an initial disruption in homeostasis…..The hormetic dose response therefore represents the effects of a reparative process that slightly or modestly overshoots the original homeostatic set point, resulting in the low-dose stimulatory response…..The assessment of the dose response therefore is a dynamic process. Whereas harmful agents may induce toxicity in affected biological systems, the organism or biological system is not a passive entity but, rather, will respond to damage signals with a coordinated series of temporally mediated repair processes. This dynamic aspect of toxicological assessment requires the inclusion of not only a broad range of doses but also a series of temporal evaluations (i.e., repeat measures). Only by assessing the dose-response process over time can an accurate assessment of the dose-response relationship be determined, within which the hormetic dose response is best revealed.” .......

SUMMARY AND CONCLUSIONS

Hormesis is a biphasic dose-response phenomenon characterized by a low-dose stimulation and a high-dose inhibition. Hormetins are substances that produce Hormesis. The present Op-ed identified many hundreds of candidate Hormetins, and provided arguments that showed many more candidate Hormetins could be identified with a well-resourced study. Fifty candidate Hormetins were evaluated, and 45 of the fifty were validated as Hormetins, a 90% success rate. Each of the 45 Hormetins was briefly addressed, in describing the evidence that linked the substance to Hormesis.

The main categories of Hormetins (candidate and validated), based on numbers of studies published, appear to be ionizing radiation, agrochemicals, soil pollutants, water pollutants, air pollutants, medications, food pollutants, heavy metals, industrial chemicals, foods, physical activities, etc. From my perspective, the main limitations are the criteria the authors use for Hormetins, and the spatiotemporal omissions of most studies reported. Typically, the authors will select a few biomarkers, examine changes in their magnitude and direction related to the application of the candidate Hormetin, and if the changes go in a specific direction, conclude that the substance resulted in Hormesis. This is very limited.

If the results of these studies are to be used in health policy-making, as some leaders in the field have suggested, then the spatiotemporal boundaries need to be expanded significantly to ensure safety. More biomarkers need to be selected to ensure global maxima of benefits are obtained rather than local maxima (e.g., short-term, single stressor). For heterogeneous populations, one would expect a distribution of susceptibility to these stressors, where some members could experience positive Hormetic effects and other members might experience negative impacts. In other words, generalizability to whole populations needs to be established. More studies need to be done including combinations of candidate Hormetins, and combinations of candidate Hormetins with real-world substances operating at toxic levels. Additionally, they need to be performed over the long-term, not limited to short-term, as many of the studies reviewed here are. Most of all, because of the limited applicability of animal studies to humans, long-term studies on humans would be required for these myriad combinations. This would require many decades of well-controlled studies on humans, to ensure longevity is not impacted adversely and diseases of old age are not enhanced.

******************************************************

No comments:

Post a Comment

All comments containing Chinese characters will not be published as I do not understand them